Johns Hopkins University and Pfizer CTI Joint Steering Committee

Johns Hopkins University and Pfizer CTI Joint Steering Committee


JHU–Pfizer CTI HOME | CTI Proposal Process
JHU and Pfizer CTI Joint Steering Committee | Frequently Asked Questions

 

The Johns Hopkins University and Pfizer CTI projects are governed by a steering committee with equal representation from The Johns Hopkins University and Pfizer. The committee selects research projects and monitors their progress.
 
 

JHU Members

Jim Barrow, Ph.D.

Associate Professor, Pharmacology and Molecular Sciences and Oncology; Lieber Institute for Brain Development

Takashi Tskuamoto, Ph.D.

Director, Medicinal Chemistry, Johns Hopkins Drug Discovery Program
Associate Professor of Neurology

Jay Pasricha, M.B.B.S., M.D.

Director, Johns Hopkins Center for Neurogastroenterology
Vice Chair of Medicine Innovation and Commercialization
Professor of Medicine and Neuroscience
 
 

CTI Members

Tony Coyle
Senior Vice President and Chief Scientific Officer, Pfizer CTI

Leigh Zawel
Vice President of Pfizer CTI, NYC and BOS Site Head

Loudmila Tchistiakova
Senior Director, Medical Sciences

 
 

Non-voting Liaisons

Sean Evans
Associate Director, Corporate Partnerships
Johns Hopkins Technology Ventures

Nader Halim, Ph.D.
Director, Worldwide Research and Development
Pfizer CTI